<DOC>
	<DOCNO>NCT01400490</DOCNO>
	<brief_summary>The goal study test efficacy EPA-enriched oil make DuPont versus DHA-enriched oil , standard fish oil preparation , olive oil placebo double-blind , randomize , placebo-controlled trial . This study compare efficacy 1800 mg/day EPA versus 1800 mg/day DHA versus fish oil product containing 1800 mg EPA 1200 mg DHA/day compare olive oil placebo 6 grams/day 6 week period parallel arm design study 120 healthy adult study fast post-prandial state . Safety monitor assess adverse reaction , measure vital sign variety lab test include complete metabolic profile complete blood count . Efficacy assess measure change fatty acid profile fatty acid ratio , well measure plasma lipid , lipoprotein , marker inflammation .</brief_summary>
	<brief_title>Eicosapentaenoic Acid ( EPA ) Docosahexaenoic Acid Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<criteria>Healthy male surgically sterile female age 2170 . Body Mass Index 2035 . Plasma Lipoprotein Associated Phospholipase A2 ( LpPLA2 ) value &gt; 200 ng/ml . Competitive exerciser . Current smoker . Those already take dietary supplement ( EPA , DHA , flax seed oil , fish oil , cod liver oil , weight control product , high dos vitamin C ( &gt; 500 mg/day ) vitamin E ( &gt; 400 mg/day ) . Those consume 3 oily fish species/week . Those consume &gt; 2 drink contain alcohol/day . Those take medication could affect serum lipid body weight , take coumadin 325 mg/day aspirin could effect bleed time coagulation profile . History bleed disorder . History significant cardiac , renal , hepatic , gastrointestinal , pulmonary , neoplastic , biliary endocrine disorder include uncontrolled diabetes , thyroid disease , hypertension . Plasma LpPLA2 value &lt; 200 ng/ml .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>